Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$713K Buy
4,394
+90
+2% +$13K 0.02% 124
2026
Q1
$508K Buy
4,304
+549
+15% +$72K 0.02% 134
2025
Q4
$447K Buy
3,755
+550
+17% +$62.6K 0.02% 132
2025
Q3
$321K Buy
3,205
+443
+16% +$52.7K 0.01% 146
2025
Q2
$356K Buy
2,762
+597
+28% +$72.7K 0.02% 118
2025
Q1
$277K Buy
2,165
+406
+23% +$58.4K 0.01% 120
2024
Q4
$269K Buy
1,759
+508
+41% +$86K 0.01% 115
2024
Q3
$224K Buy
+1,251
New +$217K 0.01% 124

Other funds holding NOVT

Summitry LLC's NOVT Position: Q2 2026 in Review

Summitry LLC increased its Novanta (NOVT) stake by 2.1% in Q2 2026, buying an estimated $13K and bringing the position to 4,394 shares worth $713K. The position accounts for 0.02% of the portfolio, ranked #124.

Summitry LLC first reported a position in NOVT in Q3 2024 and has held it in 8 quarters since. 389 funds tracked by Wall St. Rank hold NOVT as of Q2 2026.

  • Summitry LLC held 4,394 shares of Novanta worth $713K as of Q2 2026.
  • Summitry LLC bought 90 Novanta shares in Q2 2026, an estimated $13K.
  • Novanta made up 0.02% of Summitry LLC's portfolio in Q2 2026, its #124 holding.
  • Summitry LLC first reported a position in Novanta in Q3 2024 and has held it in 8 quarters since.
  • 389 funds tracked by Wall St. Rank held Novanta as of Q2 2026.

Based on Summitry LLC's 13F filing for Q2 2026, filed 21 Jul 2026.